35th Annual New Treatments in Chronic Liver Disease


HCV Eradication

Dr. Ward reviews the prevention, treatment, and goals for elimination of Hepatitis C.
John Ward, MD

John Ward, MD

Director, Coalition for Global Hepatitis Elimination
Coalition for Global Hepatitis Elimination/ Task Force for Global Health

Update on HBV Therapies

Dr. Shiffman discusses the importance of correctly interpreting Hepatitis B serologies and gives an update on cases, demographics, and treatments.
Mitchell Shiffman, MD

Mitchell Shiffman, MD

Director, Liver Institute of Virginia
Bon Secours Mercy Health

Rising Burden of Alcoholic Liver Disease

Dr. Gutierrez highlights the global trends of alcoholic liver disease and identifies prevalent risk factors to screen for.
Julio Gutierrez, MD

Julio Gutierrez, MD

Hepatologist, Gastroenterologist
Scripps Center for Organ and Cell Transplantation
Scripps MD Anderson Cancer Center
La Jolla, California

The Latest on PBC and PSC

Dr. Kowdley reviews the different clinical needs of PBC and PSC and offer several available tools to predict their clinical course.
Kris Kowdley, MD

Kris Kowdley, MD

Director, Liver Institute Northwest
Clinical Professor, College of Medicine, Washington State University

Patients with Alcoholic Hepatitis Should Undergo Liver Transplant as Primary Treatment

Drs. Gutierriez and Shiffman debate the advantages and disadvantages of patients with Alcoholic Hepatitis undergoing a liver transplant as primary treatment.
Julio Gutierrez, MD

Julio Gutierrez, MD

Hepatologist, Gastroenterologist
Scripps Center for Organ and Cell Transplantation
Scripps MD Anderson Cancer Center
La Jolla, California
Mitchell Shiffman, MD

Mitchell Shiffman, MD

Director, Liver Institute of Virginia
Bon Secours Mercy Health

Liver Day 1 Panel Discussion

Drs. Ward, Shiffman, Gutierrez, and Kowdley answer questions from course participants.
John Ward, MD

John Ward, MD

Director, Coalition for Global Hepatitis Elimination
Coalition for Global Hepatitis Elimination/ Task Force for Global Health
Mitchell Shiffman, MD

Mitchell Shiffman, MD

Director, Liver Institute of Virginia
Bon Secours Mercy Health
Julio Gutierrez, MD

Julio Gutierrez, MD

Hepatologist, Gastroenterologist
Scripps Center for Organ and Cell Transplantation
Scripps MD Anderson Cancer Center
La Jolla, California
Kris Kowdley, MD

Kris Kowdley, MD

Director, Liver Institute Northwest
Clinical Professor, College of Medicine, Washington State University

What Does the Gastroenterologist Need to Know: Systemic Therapies for HCC

Dr. Frenette offers the best practices for treating hepatocellular carcinoma (HCC).
Catherine Frenette, MD

Catherine Frenette, MD

Medical Director of Liver Transplantation
Scripps Center for Organ Transplantation
Scripps Clinic/Scripps Green Hospital
Director, Liver and Hepatocellular Cancer Program
Scripps MD Anderson Cancer Center

William S. Haubrich Memorial Lecture: Acute Liver Failure

Dr. Karvellas explores current prognostic scores, novel biomarkers, and management of ALF.
Constantine Karvellas, MD

Constantine Karvellas, MD

Professor, Division of Gastroenterology, Department of Critical Care Medicine
Adjunct Professor, School of Public Health Sciences
University of Alberta

Virtual HCC Tumor Board

Drs. Frenette, Karvellas, and Gutierrez examine several HCC cases and present their follow-ups.
Catherine Frenette, MD

Catherine Frenette, MD

Medical Director of Liver Transplantation
Scripps Center for Organ Transplantation
Scripps Clinic/Scripps Green Hospital
Director, Liver and Hepatocellular Cancer Program
Scripps MD Anderson Cancer Center
Constantine Karvellas, MD

Constantine Karvellas, MD

Professor, Division of Gastroenterology, Department of Critical Care Medicine
Adjunct Professor, School of Public Health Sciences
University of Alberta
Julio Gutierrez, MD

Julio Gutierrez, MD

Hepatologist, Gastroenterologist
Scripps Center for Organ and Cell Transplantation
Scripps MD Anderson Cancer Center
La Jolla, California

EASL Update for NASH

Dr. Rinella relays valuable takeaways from the EASL International Liver Congress including diet and weight loss approaches, biomarkers, and emerging therapeutics for Non-Alcoholic SteatoHepatitis.
Mary Rinella, MD

Mary Rinella, MD

Professor of Medicine
Northwestern Medicine

Post-Transplant Complications: What the Gastroenterology Community Needs to Know

Dr. Terrault details the elements of transplant complications such as infection, malignancy, metabolic syndrome, and recurrent liver disease.
Norah Terrault, MD

Norah Terrault, MD

Visiting Professor of Medicine, Chief, Division of Gastrointestinal and Liver
Keck School of Medicine of USC

Liver Day 2 Panel Discussion

Drs. Frenette, Karvellas, Rinella, and Terrault answer questions from course participants.
Catherine Frenette, MD

Catherine Frenette, MD

Medical Director of Liver Transplantation
Scripps Center for Organ Transplantation
Scripps Clinic/Scripps Green Hospital
Director, Liver and Hepatocellular Cancer Program
Scripps MD Anderson Cancer Center
Constantine Karvellas, MD

Constantine Karvellas, MD

Professor, Division of Gastroenterology, Department of Critical Care Medicine
Adjunct Professor, School of Public Health Sciences
University of Alberta
Mary Rinella, MD

Mary Rinella, MD

Professor of Medicine
Northwestern Medicine
Norah Terrault, MD

Norah Terrault, MD

Visiting Professor of Medicine, Chief, Division of Gastrointestinal and Liver
Keck School of Medicine of USC

Return to Main Menu »

Course Overview

This CME conference will review new medications and therapies that are now available, or will soon be available, and discuss their comparative values. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

Educational Objectives

  • Discuss the algorithm and steps to treatment and eradication of Hepatitis B and C.
  • Describe the diagnosis and treatment of common liver disease such as PBC, PSC, and new updates in the treatment of NASH.
  • Discuss what the non-transplant physician needs to know in the treatment of HCC with systemic therapies and post transplant complications.

View Faculty Disclosures »